Serum Na <135 mEq/L; evaluated by volume status and urine osmolality/sodium.
Also known as: hyponatremia, low sodium, SIADH
Overview
Serum sodium concentration <135 mEq/L. Classified by severity (mild 130-134, moderate 125-129, severe <125), acuity (acute <48 h vs chronic), tonicity (hypotonic — true hyponatremia — vs isotonic vs hypertonic pseudohyponatremia), and volume status (hypovolemic, euvolemic, hypervolemic).
Epidemiology
Most common electrolyte abnormality in hospitalized patients (~15-20%). Associated with increased morbidity, mortality, and length of stay across populations.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Hyponatremia outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Exercise-associated hyponatremia (marathon runners over-hydrating with hypotonic fluids)
Pathophysiology
True hypotonic hyponatremia results from excess water relative to sodium. ADH-driven water retention exceeds urinary water excretion capacity. Causes are categorized by volume status: hypovolemic (volume loss replaced with hypotonic fluid), euvolemic (SIADH, hypothyroid, adrenal insufficiency), hypervolemic (HF, cirrhosis, CKD/nephrotic — total body Na increased but water more so). Pseudohyponatremia: severe hyperlipidemia or hyperproteinemia causes lab artifact with normal plasma water Na.
Pseudohyponatremia — Severe hyperlipidemia, hyperproteinemia (multiple myeloma); normal measured osmolality
Translocational hyponatremia — Hyperglycemia, mannitol; correct Na = measured Na + 1.6 × ((glucose - 100)/100)
Diagnostic workup
Diagnostic criteria
Serum Na <135 + serum osm <275 = true hypotonic hyponatremia. Etiology determined by volume status + urine osmolality + urine Na (algorithmic approach).
Labs
Confirm true hypotonic hyponatremia: measure serum osmolality (low <275 mOsm/kg in true; normal in pseudohyponatremia; high in hyperglycemia or mannitol)
TSH, cortisol (or cosyntropin stimulation) to rule out hypothyroidism and adrenal insufficiency
BMP for renal function, glucose; uric acid (low in SIADH, high in cerebral salt wasting)
Imaging
Chest CT if SIADH suspected to evaluate for malignancy (especially small cell lung)
Brain MRI if CNS process suspected as cause
Diagnostic algorithm
flowchart TD
A[Serum Na <135] --> B[Serum osmolality]
B -->|Normal/High| C[Pseudohyponatremia<br/>or hyperglycemia/mannitol]
B -->|Low <275| D[True hypotonic<br/>hyponatremia]
D --> E[Assess volume status]
E -->|Hypovolemic| F[Urine Na]
F -->|<20| G[Extrarenal loss<br/>GI, skin, blood]
F -->|>40| H[Renal loss<br/>diuretic, adrenal insuff]
E -->|Euvolemic| I[Urine osm]
I -->|<100| J[Primary polydipsia<br/>low solute]
I -->|>100| K[SIADH, hypothyroid,<br/>adrenal insuff]
E -->|Hypervolemic| L[HF, cirrhosis,<br/>nephrotic, CKD]
Diagnostic algorithm for hyponatremia — serum osmolality, then volume status, then urine studies.
Treatment
First-line
Severe symptomatic (seizures, coma, focal neuro deficits):
3% hypertonic saline 100 mL IV bolus, may repeat × 2 every 10 min until symptoms improve; goal is +4-6 mEq/L rise to relieve symptoms
Maximum correction 8-10 mEq/L per 24 h (some experts allow up to 12 mEq/L); slower in chronic, malnourished, alcoholic, or hypokalemic patients to avoid osmotic demyelination
Treat underlying cause once stable
Hypovolemic hyponatremia: isotonic saline (normal saline or lactated Ringer's)
Euvolemic hyponatremia (SIADH): fluid restriction (<800-1000 mL/day) first-line; salt tablets or urea if persistent
Vasopressin receptor antagonists (vaptans): tolvaptan (oral), conivaptan (IV) — for refractory SIADH or hypervolemic hyponatremia; monitor closely due to risk of rapid correction
Demeclocycline (induces nephrogenic DI) — historical SIADH therapy, rarely used now
If overcorrection occurs (Na rises >10-12 mEq/L in 24 h): re-lower with D5W ± DDAVP to prevent osmotic demyelination
Complications
Osmotic demyelination syndrome (formerly central pontine myelinolysis) — from overly rapid correction; presents days later with dysarthria, dysphagia, paraparesis, locked-in syndrome; irreversible
Cerebral edema and herniation from severe acute hyponatremia
Seizures
Falls and fractures (chronic mild hyponatremia)
Increased mortality in hospitalized patients
PANCE pearls
First step in hyponatremia evaluation: check serum osmolality. Low (<275) = true hypotonic; normal = pseudohyponatremia; high = translocational (hyperglycemia, mannitol).
SIADH diagnostic criteria: hypotonic hyponatremia + euvolemia + urine osm >100 + urine Na >40 + normal thyroid and adrenal function + no diuretics.
Correct chronic hyponatremia SLOWLY: max 8-10 mEq/L per 24 hours to avoid osmotic demyelination syndrome. Higher-risk patients (alcoholics, malnourished, hypokalemic): even more cautious.
Acute symptomatic hyponatremia (<48 h): 3% hypertonic saline is appropriate emergency treatment regardless of chronicity concerns.
Pseudohyponatremia clue: normal serum osmolality despite low measured Na (lab artifact from hypertriglyceridemia, hyperproteinemia).
Hyperglycemia correction formula: corrected Na = measured Na + 1.6 × ((glucose − 100)/100). Each 100 mg/dL glucose rise lowers Na ~1.6 mEq/L.
References
European Society 2014 — Clinical practice guideline on diagnosis and treatment of hyponatraemia (Spasovski et al., Eur J Endocrinol 2014)
Expert Panel 2013 — Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations (Verbalis et al., Am J Med 2013)
Practice Renal/Urology questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.